Belumosudil (Rezurock)
Jump to navigation
Jump to search
Mechanism of action
ROCK2 (Rho-associated coiled-coil kinase 2) inhibitor
Diseases for which it is used
History of changes in FDA indication
- 2021-07-16: Approved for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy. (Based on ROCKstar)
Also known as
- Code names: KD-025, SLx-2119
- Brand name: Rezurock